½ÃÀ庸°í¼­
»óǰÄÚµå
1579845

¼¼°èÀÇ ÀÇ·á¿ë ¿Ü°ñ°Ý ½ÃÀå

Medical Exoskeleton

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Global Industry Analysts, Inc. | ÆäÀÌÁö Á¤º¸: ¿µ¹® 89 Pages | ¹è¼Û¾È³» : 1-2ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    



¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

ÀÇ·á¿ë ¿Ü°ñ°Ý ¼¼°è ½ÃÀå ±Ô¸ð´Â 2030³â±îÁö 65¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù

2023³â 15¾ï ´Þ·¯·Î ÃßÁ¤µÇ´Â ÀÇ·á¿ë ¿Ü°ñ°Ý ¼¼°è ½ÃÀåÀº 2023-2030³âÀÇ ºÐ¼® ±â°£ µ¿¾È ¿¬Æò±Õ 23.1% ¼ºÀåÇÏ¿© 2030³â¿¡´Â 65¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. º» º¸°í¼­¿¡¼­ ºÐ¼®ÇÑ ºÎ¹® Áß ÇϳªÀÎ Çϵå¿þ¾î´Â CAGR 20.2%¸¦ ±â·ÏÇÏ¿© ºÐ¼® ±â°£ ¸»¿¡ 32¾ï ´Þ·¯¿¡ µµ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¼ÒÇÁÆ®¿þ¾î ºÐ¾ßÀÇ ¼ºÀå·üÀº ºÐ¼® ±â°£ µ¿¾È 26.4%ÀÇ ¿¬Æò±Õ º¹ÇÕ ¼ºÀå·ü(CAGR)À» ³ªÅ¸³¾ °ÍÀ¸·Î ÃßÁ¤µË´Ï´Ù.

¹Ì±¹ ½ÃÀå 4¾ï 3,560¸¸ ´Þ·¯·Î ÃßÁ¤, Áß±¹Àº CAGR 21.2%·Î ¼ºÀå Àü¸Á

¹Ì±¹ÀÇ ÀÇ·á¿ë ¿Ü°ñ°Ý ½ÃÀåÀº 2023³â 4¾ï 3,560¸¸ ´Þ·¯·Î ÃßÁ¤µË´Ï´Ù. ¼¼°è 2À§ÀÇ °æÁ¦ ´ë±¹ÀÎ Áß±¹Àº 2023-2030³â ¿¬Æò±Õ 21.2%ÀÇ ¼ºÀå·üÀ» º¸À̸ç 2030³â¿¡´Â 9¾ï 1,410¸¸ ´Þ·¯ ±Ô¸ð¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ´Ù¸¥ ÁÖ¸ñÇÒ ¸¸ÇÑ Áö¿ª ½ÃÀåÀ¸·Î´Â ÀϺ»°ú ij³ª´Ù°¡ ºÐ¼® ±â°£ µ¿¾È °¢°¢ 19.6%¿Í 19.1%ÀÇ ¿¬Æò±Õ º¹ÇÕ ¼ºÀå·ü(CAGR)À» ³ªÅ¸³¾ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. À¯·´¿¡¼­´Â µ¶ÀÏÀÌ ¾à 13.4%ÀÇ ¿¬Æò±Õ º¹ÇÕ ¼ºÀå·ü(CAGR)À» ³ªÅ¸³¾ Àü¸ÁÀÔ´Ï´Ù.

¼¼°è ÀÇ·á¿ë ¿Ü°ñ°Ý ½ÃÀå - ÁÖ¿ä µ¿Çâ ¹× ÃËÁø¿äÀÎ ¿ä¾à

ÀÇ·á¿ë ¿Ü°ñ°ÝÀº ÇコÄɾîÀÇ À̵¿¼ºÀ» ¾î¶»°Ô ÀçÁ¤ÀÇÇϰí Àִ°¡?

ÀÇ·á¿ë ¿Ü°ñ°ÝÀº ô¼ö ¼Õ»ó¿¡¼­ ȸº¹µÈ »ç¶÷À̳ª ´Ù¹ß¼º °æÈ­Áõ, ³úÁ¹Áß°ú °°Àº Áúº´À» ¾Î°í ÀÖ´Â »ç¶÷ µî °Åµ¿ÀÌ ºÒÆíÇÑ »ç¶÷µé¿¡°Ô µ¿·Â Áö¿øÀ» Á¦°øÇÏ´Â ¿þ¾î·¯ºí ±â±âÀÔ´Ï´Ù. ÀÌ ÀåÄ¡´Â »ç¿ëÀÚÀÇ º¸Çà, ±â¸³, ½ÉÁö¾î ÀçȰ ¿îµ¿ ¼öÇàÀ» µµ¿Í »îÀÇ ÁúÀ» Å©°Ô Çâ»ó½Ãų ¼ö ÀÖ½À´Ï´Ù. ÀÇ·á¿ë ¿Ü°ñ°ÝÀº ȸº¹À» ÃËÁøÇÏ°í ¿îµ¿ ´É·ÂÀ» ȸº¹ÇÏ´Â µ¥ »ç¿ëµÇ´Â ÀçȰ¼¾ÅÍ¿Í º´¿ø¿¡¼­ Á¡Á¡ ´õ ¸¹ÀÌ »ç¿ëµÇ°í ÀÖ½À´Ï´Ù. ¿Ü°ñ°ÝÀº ½ÅüÀû º¸Á¶¸¦ °­È­ÇÏ¿© ȯÀÚÀÇ ÀÚ¸³À» µ½°í °£º´Àΰú ÀÇ·á Àü¹®°¡ÀÇ ºÎ´ãÀ» ´ú¾îÁÝ´Ï´Ù.

¾î¶² Çõ½ÅÀÌ ÀÇ·á¿ë ¿Ü°ñ°Ý ½ÃÀåÀ» Çü¼ºÇϰí Àִ°¡?

ÀÇ·á¿ë ¿Ü°ñ°ÝÀÇ Çõ½Å¿¡´Â ·Îº¿ °øÇÐ, °æ·® ¼ÒÀç, AI ±â¹Ý ¿îµ¿ Á¦¾î ½Ã½ºÅÛÀÇ ¹ßÀüÀÌ Æ÷ÇԵ˴ϴÙ. ÀÌ·¯ÇÑ ¹ßÀüÀº º¸´Ù Á÷°üÀûÀÌ°í ¹ÝÀÀ¼ºÀÌ ¶Ù¾î³­ ¿Ü°ñ°ÝÀ¸·Î º¸´Ù ºÎµå·´°í ÀÚ¿¬½º·¯¿î ¿òÁ÷ÀÓÀ» °¡´ÉÇÏ°Ô Çϰí, AIÀÇ ÅëÇÕÀ¸·Î ¿Ü°ñ°ÝÀÌ »ç¿ëÀÚÀÇ ¿òÁ÷ÀÓÀ» ÇнÀÇÏ°í ½Ç½Ã°£À¸·Î Á¶Á¤ÇÒ ¼ö ÀÖ¾î Àå±âÀûÀÎ ÀçȰ¿¡ ´õ È¿°úÀûÀÏ ¼ö ÀÖµµ·Ï µ½°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ź¼Ò¼¶À¯¿Í ÷´Ü Æú¸®¸Ó¿Í °°Àº ½Å¼ÒÀç ´öºÐ¿¡ ¿Ü°ñ°ÝÀÇ ¹«°Ô°¡ °¡º­¿öÁö°í Âø¿ë°¨ÀÌ Çâ»óµÇ¾ú½À´Ï´Ù. ¹èÅ͸® ±â¼úµµ °³¼±µÇ¾î ÀæÀº ÃæÀü ¾øÀ̵µ ¿Ü°ñ°ÝÀ» Àå±â°£ »ç¿ëÇÒ ¼ö ÀÖ°Ô µÇ¾ú½À´Ï´Ù.

½ÃÀå ¼¼ºÐÈ­´Â ÀÇ·á¿ë ¿Ü°ñ°ÝÀÇ ¼ºÀåÀ» ¾î¶»°Ô Á¤ÀÇÇϴ°¡?

À¯Çü¿¡´Â µ¿·Â½Ä ¿Ü°ñ°Ý°ú ¼öµ¿½Ä ¿Ü°ñ°ÝÀÌ ÀÖÀ¸¸ç, µ¿·Â½Ä ¿Ü°ñ°ÝÀº ´õ Å« À̵¿ Áö¿øÀ» Á¦°øÇÒ ¼ö Àֱ⠶§¹®¿¡ °¡Àå Å« Á¡À¯À²À» Â÷ÁöÇÕ´Ï´Ù. ¿ëµµ´Â ÀçȰ¿¡¼­ ÀÏ»ó »ýȰ º¸Á¶ ÀåÄ¡±îÁö ´Ù¾çÇÏÁö¸¸, ÀçȰÀº ¹°¸®Ä¡·á¿¡ ³Î¸® »ç¿ëµÇ±â ¶§¹®¿¡ ÀçȰÀÌ ÁÖ¿ä ºÎ¹®À¸·Î ²ÅÈ÷°í ÀÖ½À´Ï´Ù. ÃÖÁ¾ »ç¿ëÀÚ¿¡´Â º´¿ø, ÀçȰ¼¾ÅÍ, ÀçÅà ¿ä¾ç ±â°üÀÌ Æ÷ÇԵǸç, º´¿ø°ú ÀçȰ¼¾ÅͰ¡ Áö¹èÀûÀÎ ºÐ¾ßÀÔ´Ï´Ù. Áö¸®ÀûÀ¸·Î ºÏ¹Ì°¡ ½ÃÀåÀ» ÁÖµµÇϰí À¯·´ÀÌ ±× µÚ¸¦ ÀÕ°í ÀÖÀ¸¸ç, ¾Æ½Ã¾ÆÅÂÆò¾çÀº ÇコÄÉ¾î ±â¼ú¿¡ ´ëÇÑ ÅõÀÚ Áõ°¡·Î ÀÎÇØ ºü¸£°Ô ¼ºÀåÇϰí ÀÖ½À´Ï´Ù.

ÀÇ·á¿ë ¿Ü°ñ°Ý ½ÃÀåÀÇ ¼ºÀåÀ» °¡¼ÓÇÏ´Â ¿äÀÎÀº ¹«¾ùÀΰ¡?

ÀÇ·á¿ë ¿Ü°ñ°Ý ½ÃÀåÀÇ ¼ºÀåÀº ½Å°æ ¹× ¿îµ¿ Àå¾ÖÀÇ À¯º´·ü Áõ°¡, ·Îº¿ °øÇÐ ¹× AIÀÇ ¹ßÀü, ÀçȰ ±â¼ú¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡ µî ¿©·¯ °¡Áö ¿äÀο¡ ±âÀÎÇÕ´Ï´Ù. Àü ¼¼°è Àα¸ÀÇ °í·ÉÈ­·Î ÀÎÇØ À̵¿ Àå¾Ö ¹ß»ý·üÀÌ Áõ°¡Çϸ鼭 ¿Ü°ñ°Ý°ú °°Àº º¸Á¶ ±â¼ú¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ·Îº¿ °øÇÐ ¹× µ¿ÀÛ Á¦¾î ½Ã½ºÅÛÀÇ ¹ßÀüÀº ÀÌ·¯ÇÑ ÀåÄ¡¸¦ º¸´Ù È¿°úÀûÀÌ°í ½±°Ô »ç¿ëÇÒ ¼ö ÀÖ°Ô ¸¸µé¾î ½ÃÀå ¼ºÀåÀ» ´õ¿í ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ÀçȰÀ» ÅëÇÑ È¯ÀÚ ¿¹ÈÄ °³¼±¿¡ ´ëÇÑ °ü½ÉÀÌ ³ô¾ÆÁö°í ÀÇ·á¿ë ¿Ü°ñ°Ý¿¡ ´ëÇÑ º¸Çè Àû¿ë °¡´É¼ºÀÌ ³ô¾ÆÁü¿¡ µû¶ó ½ÃÀå È®´ë¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù.

Á¶»ç ´ë»ó ±â¾÷ ¿¹½Ã(ÃÑ 34°Ç)

  • Bionik Laboratories Corp
  • B-TEMIA Inc.
  • Cyberdyne Inc.
  • Ekso Bionics Holdings, Inc.
  • ExoAtlet
  • Gogoa Mobility Robots SL
  • Hocoma AG(DIH TechnologiesÀÇ ÀÚȸ»ç)
  • Parker Hannifin Corp
  • ReWalk Robotics Ltd
  • Rex Bionics Ltd.
  • Tyromotion GmbH
  • US Bionics
  • Wearable Robotics SRL

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý

Á¦2Àå ÁÖ¿ä ¿ä¾à

  • ½ÃÀå °³¿ä
  • ÁÖ¿ä ±â¾÷
  • ½ÃÀå µ¿Çâ°ú ÃËÁø¿äÀÎ
  • ¼¼°è ½ÃÀå Àü¸Á

Á¦3Àå ½ÃÀå ºÐ¼®

  • ¹Ì±¹
  • ij³ª´Ù
  • ÀϺ»
  • Áß±¹
  • À¯·´
  • ÇÁ¶û½º
  • µ¶ÀÏ
  • ÀÌÅ»¸®¾Æ
  • ¿µ±¹
  • ±âŸ À¯·´
  • ¾Æ½Ã¾ÆÅÂÆò¾ç
  • ±âŸ Áö¿ª

Á¦4Àå °æÀï

LSH 24.11.06

Global Medical Exoskeleton Market to Reach US$6.5 Billion by 2030

The global market for Medical Exoskeleton estimated at US$1.5 Billion in the year 2023, is expected to reach US$6.5 Billion by 2030, growing at a CAGR of 23.1% over the analysis period 2023-2030. HardwareComponent, one of the segments analyzed in the report, is expected to record a 20.2% CAGR and reach US$3.2 Billion by the end of the analysis period. Growth in the Software Component segment is estimated at 26.4% CAGR over the analysis period.

The U.S. Market is Estimated at US$435.6 Million While China is Forecast to Grow at 21.2% CAGR

The Medical Exoskeleton market in the U.S. is estimated at US$435.6 Million in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$914.1 Million by the year 2030 trailing a CAGR of 21.2% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 19.6% and 19.1% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 13.4% CAGR.

Global Medical Exoskeleton Market - Key Trends and Drivers Summarized

How Are Medical Exoskeletons Redefining Mobility in Healthcare?

Medical exoskeletons are wearable devices that provide powered support to individuals with mobility impairments, such as those recovering from spinal cord injuries or suffering from conditions like multiple sclerosis or stroke. These devices assist users in walking, standing, and even performing rehabilitation exercises, greatly improving their quality of life. Medical exoskeletons are increasingly being adopted in rehabilitation centers and hospitals, where they are used to accelerate recovery and restore mobility. By offering enhanced physical assistance, exoskeletons are also enabling patients to achieve greater independence, reducing the burden on caregivers and healthcare professionals.

What Innovations Are Shaping the Medical Exoskeleton Market?

Innovations in medical exoskeletons include advancements in robotics, lightweight materials, and AI-driven motion control systems. These developments are enabling more intuitive and responsive exoskeletons, allowing for smoother and more natural movements. The integration of AI is helping exoskeletons learn from user movements and adjust in real-time, making them more effective for long-term rehabilitation. Additionally, exoskeletons are becoming lighter and more comfortable to wear, thanks to new materials such as carbon fiber and advanced polymers. Battery technology is also improving, allowing exoskeletons to be used for longer periods without the need for frequent recharging.

How Do Market Segments Define the Growth of Medical Exoskeletons?

Types include powered and passive exoskeletons, with powered exoskeletons accounting for the largest share due to their ability to provide greater mobility assistance. Applications range from rehabilitation to assistive devices for daily use, with rehabilitation being the primary segment as these devices are widely used in physical therapy. End-users include hospitals, rehabilitation centers, and home care settings, with hospitals and rehabilitation centers being the dominant sectors. Geographically, North America leads the market, followed by Europe, while Asia-Pacific is seeing rapid growth due to increasing investments in healthcare technology.

What Factors Are Driving the Growth in the Medical Exoskeleton Market?

The growth in the medical exoskeleton market is driven by several factors, including the increasing prevalence of neurological and mobility disorders, advancements in robotics and AI, and rising demand for rehabilitation technologies. As the global population ages, the incidence of mobility impairments is rising, driving demand for assistive technologies like exoskeletons. Advances in robotics and motion control systems are making these devices more effective and accessible, further boosting market growth. Additionally, the growing focus on improving patient outcomes through rehabilitation and the increasing availability of insurance coverage for medical exoskeletons are contributing to the market's expansion.

Select Competitors (Total 34 Featured) -

  • Bionik Laboratories Corp
  • B-TEMIA Inc.
  • Cyberdyne Inc.
  • Ekso Bionics Holdings, Inc.
  • ExoAtlet
  • Gogoa Mobility Robots SL
  • Hocoma AG (A Subsidiary of DIH Technologies)
  • Parker Hannifin Corp
  • ReWalk Robotics Ltd
  • Rex Bionics Ltd.
  • Tyromotion GmbH
  • US Bionics
  • Wearable Robotics SRL

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Global Economic Update
    • Medical Exoskeleton - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Demand for Rehabilitation and Mobility Assistance Drives Growth in Medical Exoskeleton Market
    • Technological Advancements in Wearable Exoskeletons Strengthen Business Case for Adoption
    • Growing Focus on Improving Mobility in Patients with Disabilities Expands Addressable Market for Exoskeletons
    • Expansion of Medical Exoskeletons in Physical Therapy and Neurological Rehabilitation Fuels Market Growth
    • Increasing Adoption of Powered Exoskeletons for Spinal Cord Injury Patients Expands Market Opportunities
    • Technological Innovations in Lightweight and Battery-Powered Exoskeletons Propel Market Expansion
    • Rising Focus on Enhancing Patient Independence and Quality of Life Drives Demand for Medical Exoskeletons
    • Growing Use of Medical Exoskeletons in Stroke Recovery and Gait Training Expands Market Potential
    • Focus on Reducing Rehabilitation Time and Improving Therapy Outcomes Strengthens Demand for Exoskeletons
    • Rising Adoption of Medical Exoskeletons in Elderly Care and Assisted Living Facilities Expands Addressable Market
    • Technological Advancements in AI-Enabled and Smart Exoskeleton Systems Propel Market Growth
    • Rising Demand for Pediatric Exoskeletons for Mobility Assistance Expands Market Opportunities
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Medical Exoskeleton by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
    • TABLE 2: World Historic Review for Medical Exoskeleton by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2022 and % CAGR
    • TABLE 3: World 18-Year Perspective for Medical Exoskeleton by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2012, 2024 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Hardware by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
    • TABLE 5: World Historic Review for Hardware by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2022 and % CAGR
    • TABLE 6: World 18-Year Perspective for Hardware by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2024 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Software by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
    • TABLE 8: World Historic Review for Software by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2022 and % CAGR
    • TABLE 9: World 18-Year Perspective for Software by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2024 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Powered by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
    • TABLE 11: World Historic Review for Powered by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2022 and % CAGR
    • TABLE 12: World 18-Year Perspective for Powered by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2024 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for Passive by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
    • TABLE 14: World Historic Review for Passive by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2022 and % CAGR
    • TABLE 15: World 18-Year Perspective for Passive by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2024 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Mobile by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
    • TABLE 17: World Historic Review for Mobile by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2022 and % CAGR
    • TABLE 18: World 18-Year Perspective for Mobile by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2024 & 2030
    • TABLE 19: World Recent Past, Current & Future Analysis for Stationary by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
    • TABLE 20: World Historic Review for Stationary by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2022 and % CAGR
    • TABLE 21: World 18-Year Perspective for Stationary by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2024 & 2030
    • TABLE 22: World Medical Exoskeleton Market Analysis of Annual Sales in US$ for Years 2012 through 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Medical Exoskeleton Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 23: USA Recent Past, Current & Future Analysis for Medical Exoskeleton by Component - Hardware and Software - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 24: USA Historic Review for Medical Exoskeleton by Component - Hardware and Software Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2022 and % CAGR
    • TABLE 25: USA 18-Year Perspective for Medical Exoskeleton by Component - Percentage Breakdown of Value Sales for Hardware and Software for the Years 2012, 2024 & 2030
    • TABLE 26: USA Recent Past, Current & Future Analysis for Medical Exoskeleton by Type - Powered and Passive - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 27: USA Historic Review for Medical Exoskeleton by Type - Powered and Passive Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2022 and % CAGR
    • TABLE 28: USA 18-Year Perspective for Medical Exoskeleton by Type - Percentage Breakdown of Value Sales for Powered and Passive for the Years 2012, 2024 & 2030
    • TABLE 29: USA Recent Past, Current & Future Analysis for Medical Exoskeleton by Mobility - Mobile and Stationary - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 30: USA Historic Review for Medical Exoskeleton by Mobility - Mobile and Stationary Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2022 and % CAGR
    • TABLE 31: USA 18-Year Perspective for Medical Exoskeleton by Mobility - Percentage Breakdown of Value Sales for Mobile and Stationary for the Years 2012, 2024 & 2030
  • CANADA
    • TABLE 32: Canada Recent Past, Current & Future Analysis for Medical Exoskeleton by Component - Hardware and Software - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 33: Canada Historic Review for Medical Exoskeleton by Component - Hardware and Software Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2022 and % CAGR
    • TABLE 34: Canada 18-Year Perspective for Medical Exoskeleton by Component - Percentage Breakdown of Value Sales for Hardware and Software for the Years 2012, 2024 & 2030
    • TABLE 35: Canada Recent Past, Current & Future Analysis for Medical Exoskeleton by Type - Powered and Passive - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 36: Canada Historic Review for Medical Exoskeleton by Type - Powered and Passive Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2022 and % CAGR
    • TABLE 37: Canada 18-Year Perspective for Medical Exoskeleton by Type - Percentage Breakdown of Value Sales for Powered and Passive for the Years 2012, 2024 & 2030
    • TABLE 38: Canada Recent Past, Current & Future Analysis for Medical Exoskeleton by Mobility - Mobile and Stationary - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 39: Canada Historic Review for Medical Exoskeleton by Mobility - Mobile and Stationary Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2022 and % CAGR
    • TABLE 40: Canada 18-Year Perspective for Medical Exoskeleton by Mobility - Percentage Breakdown of Value Sales for Mobile and Stationary for the Years 2012, 2024 & 2030
  • JAPAN
    • Medical Exoskeleton Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 41: Japan Recent Past, Current & Future Analysis for Medical Exoskeleton by Component - Hardware and Software - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 42: Japan Historic Review for Medical Exoskeleton by Component - Hardware and Software Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2022 and % CAGR
    • TABLE 43: Japan 18-Year Perspective for Medical Exoskeleton by Component - Percentage Breakdown of Value Sales for Hardware and Software for the Years 2012, 2024 & 2030
    • TABLE 44: Japan Recent Past, Current & Future Analysis for Medical Exoskeleton by Type - Powered and Passive - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 45: Japan Historic Review for Medical Exoskeleton by Type - Powered and Passive Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2022 and % CAGR
    • TABLE 46: Japan 18-Year Perspective for Medical Exoskeleton by Type - Percentage Breakdown of Value Sales for Powered and Passive for the Years 2012, 2024 & 2030
    • TABLE 47: Japan Recent Past, Current & Future Analysis for Medical Exoskeleton by Mobility - Mobile and Stationary - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 48: Japan Historic Review for Medical Exoskeleton by Mobility - Mobile and Stationary Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2022 and % CAGR
    • TABLE 49: Japan 18-Year Perspective for Medical Exoskeleton by Mobility - Percentage Breakdown of Value Sales for Mobile and Stationary for the Years 2012, 2024 & 2030
  • CHINA
    • Medical Exoskeleton Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 50: China Recent Past, Current & Future Analysis for Medical Exoskeleton by Component - Hardware and Software - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 51: China Historic Review for Medical Exoskeleton by Component - Hardware and Software Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2022 and % CAGR
    • TABLE 52: China 18-Year Perspective for Medical Exoskeleton by Component - Percentage Breakdown of Value Sales for Hardware and Software for the Years 2012, 2024 & 2030
    • TABLE 53: China Recent Past, Current & Future Analysis for Medical Exoskeleton by Type - Powered and Passive - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 54: China Historic Review for Medical Exoskeleton by Type - Powered and Passive Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2022 and % CAGR
    • TABLE 55: China 18-Year Perspective for Medical Exoskeleton by Type - Percentage Breakdown of Value Sales for Powered and Passive for the Years 2012, 2024 & 2030
    • TABLE 56: China Recent Past, Current & Future Analysis for Medical Exoskeleton by Mobility - Mobile and Stationary - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 57: China Historic Review for Medical Exoskeleton by Mobility - Mobile and Stationary Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2022 and % CAGR
    • TABLE 58: China 18-Year Perspective for Medical Exoskeleton by Mobility - Percentage Breakdown of Value Sales for Mobile and Stationary for the Years 2012, 2024 & 2030
  • EUROPE
    • Medical Exoskeleton Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 59: Europe Recent Past, Current & Future Analysis for Medical Exoskeleton by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
    • TABLE 60: Europe Historic Review for Medical Exoskeleton by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2022 and % CAGR
    • TABLE 61: Europe 18-Year Perspective for Medical Exoskeleton by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2012, 2024 & 2030
    • TABLE 62: Europe Recent Past, Current & Future Analysis for Medical Exoskeleton by Component - Hardware and Software - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 63: Europe Historic Review for Medical Exoskeleton by Component - Hardware and Software Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2022 and % CAGR
    • TABLE 64: Europe 18-Year Perspective for Medical Exoskeleton by Component - Percentage Breakdown of Value Sales for Hardware and Software for the Years 2012, 2024 & 2030
    • TABLE 65: Europe Recent Past, Current & Future Analysis for Medical Exoskeleton by Type - Powered and Passive - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 66: Europe Historic Review for Medical Exoskeleton by Type - Powered and Passive Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2022 and % CAGR
    • TABLE 67: Europe 18-Year Perspective for Medical Exoskeleton by Type - Percentage Breakdown of Value Sales for Powered and Passive for the Years 2012, 2024 & 2030
    • TABLE 68: Europe Recent Past, Current & Future Analysis for Medical Exoskeleton by Mobility - Mobile and Stationary - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 69: Europe Historic Review for Medical Exoskeleton by Mobility - Mobile and Stationary Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2022 and % CAGR
    • TABLE 70: Europe 18-Year Perspective for Medical Exoskeleton by Mobility - Percentage Breakdown of Value Sales for Mobile and Stationary for the Years 2012, 2024 & 2030
  • FRANCE
    • Medical Exoskeleton Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 71: France Recent Past, Current & Future Analysis for Medical Exoskeleton by Component - Hardware and Software - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 72: France Historic Review for Medical Exoskeleton by Component - Hardware and Software Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2022 and % CAGR
    • TABLE 73: France 18-Year Perspective for Medical Exoskeleton by Component - Percentage Breakdown of Value Sales for Hardware and Software for the Years 2012, 2024 & 2030
    • TABLE 74: France Recent Past, Current & Future Analysis for Medical Exoskeleton by Type - Powered and Passive - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 75: France Historic Review for Medical Exoskeleton by Type - Powered and Passive Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2022 and % CAGR
    • TABLE 76: France 18-Year Perspective for Medical Exoskeleton by Type - Percentage Breakdown of Value Sales for Powered and Passive for the Years 2012, 2024 & 2030
    • TABLE 77: France Recent Past, Current & Future Analysis for Medical Exoskeleton by Mobility - Mobile and Stationary - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 78: France Historic Review for Medical Exoskeleton by Mobility - Mobile and Stationary Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2022 and % CAGR
    • TABLE 79: France 18-Year Perspective for Medical Exoskeleton by Mobility - Percentage Breakdown of Value Sales for Mobile and Stationary for the Years 2012, 2024 & 2030
  • GERMANY
    • Medical Exoskeleton Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 80: Germany Recent Past, Current & Future Analysis for Medical Exoskeleton by Component - Hardware and Software - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 81: Germany Historic Review for Medical Exoskeleton by Component - Hardware and Software Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2022 and % CAGR
    • TABLE 82: Germany 18-Year Perspective for Medical Exoskeleton by Component - Percentage Breakdown of Value Sales for Hardware and Software for the Years 2012, 2024 & 2030
    • TABLE 83: Germany Recent Past, Current & Future Analysis for Medical Exoskeleton by Type - Powered and Passive - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 84: Germany Historic Review for Medical Exoskeleton by Type - Powered and Passive Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2022 and % CAGR
    • TABLE 85: Germany 18-Year Perspective for Medical Exoskeleton by Type - Percentage Breakdown of Value Sales for Powered and Passive for the Years 2012, 2024 & 2030
    • TABLE 86: Germany Recent Past, Current & Future Analysis for Medical Exoskeleton by Mobility - Mobile and Stationary - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 87: Germany Historic Review for Medical Exoskeleton by Mobility - Mobile and Stationary Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2022 and % CAGR
    • TABLE 88: Germany 18-Year Perspective for Medical Exoskeleton by Mobility - Percentage Breakdown of Value Sales for Mobile and Stationary for the Years 2012, 2024 & 2030
  • ITALY
    • TABLE 89: Italy Recent Past, Current & Future Analysis for Medical Exoskeleton by Component - Hardware and Software - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 90: Italy Historic Review for Medical Exoskeleton by Component - Hardware and Software Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2022 and % CAGR
    • TABLE 91: Italy 18-Year Perspective for Medical Exoskeleton by Component - Percentage Breakdown of Value Sales for Hardware and Software for the Years 2012, 2024 & 2030
    • TABLE 92: Italy Recent Past, Current & Future Analysis for Medical Exoskeleton by Type - Powered and Passive - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 93: Italy Historic Review for Medical Exoskeleton by Type - Powered and Passive Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2022 and % CAGR
    • TABLE 94: Italy 18-Year Perspective for Medical Exoskeleton by Type - Percentage Breakdown of Value Sales for Powered and Passive for the Years 2012, 2024 & 2030
    • TABLE 95: Italy Recent Past, Current & Future Analysis for Medical Exoskeleton by Mobility - Mobile and Stationary - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 96: Italy Historic Review for Medical Exoskeleton by Mobility - Mobile and Stationary Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2022 and % CAGR
    • TABLE 97: Italy 18-Year Perspective for Medical Exoskeleton by Mobility - Percentage Breakdown of Value Sales for Mobile and Stationary for the Years 2012, 2024 & 2030
  • UNITED KINGDOM
    • Medical Exoskeleton Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 98: UK Recent Past, Current & Future Analysis for Medical Exoskeleton by Component - Hardware and Software - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 99: UK Historic Review for Medical Exoskeleton by Component - Hardware and Software Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2022 and % CAGR
    • TABLE 100: UK 18-Year Perspective for Medical Exoskeleton by Component - Percentage Breakdown of Value Sales for Hardware and Software for the Years 2012, 2024 & 2030
    • TABLE 101: UK Recent Past, Current & Future Analysis for Medical Exoskeleton by Type - Powered and Passive - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 102: UK Historic Review for Medical Exoskeleton by Type - Powered and Passive Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2022 and % CAGR
    • TABLE 103: UK 18-Year Perspective for Medical Exoskeleton by Type - Percentage Breakdown of Value Sales for Powered and Passive for the Years 2012, 2024 & 2030
    • TABLE 104: UK Recent Past, Current & Future Analysis for Medical Exoskeleton by Mobility - Mobile and Stationary - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 105: UK Historic Review for Medical Exoskeleton by Mobility - Mobile and Stationary Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2022 and % CAGR
    • TABLE 106: UK 18-Year Perspective for Medical Exoskeleton by Mobility - Percentage Breakdown of Value Sales for Mobile and Stationary for the Years 2012, 2024 & 2030
  • REST OF EUROPE
    • TABLE 107: Rest of Europe Recent Past, Current & Future Analysis for Medical Exoskeleton by Component - Hardware and Software - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 108: Rest of Europe Historic Review for Medical Exoskeleton by Component - Hardware and Software Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2022 and % CAGR
    • TABLE 109: Rest of Europe 18-Year Perspective for Medical Exoskeleton by Component - Percentage Breakdown of Value Sales for Hardware and Software for the Years 2012, 2024 & 2030
    • TABLE 110: Rest of Europe Recent Past, Current & Future Analysis for Medical Exoskeleton by Type - Powered and Passive - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 111: Rest of Europe Historic Review for Medical Exoskeleton by Type - Powered and Passive Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2022 and % CAGR
    • TABLE 112: Rest of Europe 18-Year Perspective for Medical Exoskeleton by Type - Percentage Breakdown of Value Sales for Powered and Passive for the Years 2012, 2024 & 2030
    • TABLE 113: Rest of Europe Recent Past, Current & Future Analysis for Medical Exoskeleton by Mobility - Mobile and Stationary - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 114: Rest of Europe Historic Review for Medical Exoskeleton by Mobility - Mobile and Stationary Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2022 and % CAGR
    • TABLE 115: Rest of Europe 18-Year Perspective for Medical Exoskeleton by Mobility - Percentage Breakdown of Value Sales for Mobile and Stationary for the Years 2012, 2024 & 2030
  • ASIA-PACIFIC
    • Medical Exoskeleton Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 116: Asia-Pacific Recent Past, Current & Future Analysis for Medical Exoskeleton by Component - Hardware and Software - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 117: Asia-Pacific Historic Review for Medical Exoskeleton by Component - Hardware and Software Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2022 and % CAGR
    • TABLE 118: Asia-Pacific 18-Year Perspective for Medical Exoskeleton by Component - Percentage Breakdown of Value Sales for Hardware and Software for the Years 2012, 2024 & 2030
    • TABLE 119: Asia-Pacific Recent Past, Current & Future Analysis for Medical Exoskeleton by Type - Powered and Passive - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 120: Asia-Pacific Historic Review for Medical Exoskeleton by Type - Powered and Passive Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2022 and % CAGR
    • TABLE 121: Asia-Pacific 18-Year Perspective for Medical Exoskeleton by Type - Percentage Breakdown of Value Sales for Powered and Passive for the Years 2012, 2024 & 2030
    • TABLE 122: Asia-Pacific Recent Past, Current & Future Analysis for Medical Exoskeleton by Mobility - Mobile and Stationary - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 123: Asia-Pacific Historic Review for Medical Exoskeleton by Mobility - Mobile and Stationary Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2022 and % CAGR
    • TABLE 124: Asia-Pacific 18-Year Perspective for Medical Exoskeleton by Mobility - Percentage Breakdown of Value Sales for Mobile and Stationary for the Years 2012, 2024 & 2030
  • REST OF WORLD
    • TABLE 125: Rest of World Recent Past, Current & Future Analysis for Medical Exoskeleton by Component - Hardware and Software - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 126: Rest of World Historic Review for Medical Exoskeleton by Component - Hardware and Software Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2022 and % CAGR
    • TABLE 127: Rest of World 18-Year Perspective for Medical Exoskeleton by Component - Percentage Breakdown of Value Sales for Hardware and Software for the Years 2012, 2024 & 2030
    • TABLE 128: Rest of World Recent Past, Current & Future Analysis for Medical Exoskeleton by Type - Powered and Passive - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 129: Rest of World Historic Review for Medical Exoskeleton by Type - Powered and Passive Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2022 and % CAGR
    • TABLE 130: Rest of World 18-Year Perspective for Medical Exoskeleton by Type - Percentage Breakdown of Value Sales for Powered and Passive for the Years 2012, 2024 & 2030
    • TABLE 131: Rest of World Recent Past, Current & Future Analysis for Medical Exoskeleton by Mobility - Mobile and Stationary - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 132: Rest of World Historic Review for Medical Exoskeleton by Mobility - Mobile and Stationary Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2022 and % CAGR
    • TABLE 133: Rest of World 18-Year Perspective for Medical Exoskeleton by Mobility - Percentage Breakdown of Value Sales for Mobile and Stationary for the Years 2012, 2024 & 2030

IV. COMPETITION

ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦